| Value | ₹17.19 Cr |
|---|---|
| Execution period | Share Purchase Agreement signed on 18th April, 2026 |
NSE filing, NSE: STARCEMENT. Summary written from the filing by ALFA Finder's alert engine.
Star Cement Ltd: key numbers
- Share price
- ₹171.10
- Market cap
- ₹6,916 Cr
- Revenue (annual)
- ₹3,776 Cr
- Net profit (annual)
- ₹393.4 Cr
- P/E (TTM)
- 18.7×Sector 32.2×
- Promoter holding
- 58.11%+0.01% QoQ
- FII holding
- 1.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Cement Ltd
All →Star Cement Board Meeting Date
Star Cement Ltd intimated that its Board meeting is scheduled for 06 Nov 2026 to approve Q2/H1 FY27 unaudited results. No financial figures are disclosed yet.
Star Cement Annual General Meeting
Star Cement held its 25th Annual General Meeting on September 25, 2026. The company approved financial statements, director appointments, and limits for material related-party transactions.
Star Cement Promoter Buying (Off-Market)
Promoter group members executed an off-market gift transfer of shares. Arushi Kejriwal acquired 1,50,749 shares, while Saroj Kejriwal transferred 1,02,074 shares.
Star Cement Annual Report
Star Cement issued a corrigendum to its FY 2025-26 Annual Report to include the inadvertently omitted Independent Auditors Certificate on Corporate Governance.
Star Cement Other Announcement
Star Cement notified shareholders with unregistered emails of the 25th AGM and provided the web-link to access the Annual Report for the 2025-26 financial year.
Star Cement Annual General Meeting
Star Cement Limited submitted its Annual Report and Notice for the 25th Annual General Meeting scheduled for September 25, 2026, via video conferencing.
Other acquisition announcements
All →Bondada Engineering Acquisition
Bondada Engineering's subsidiary ATPL acquired 51% of BTM Mobility Pvt Ltd, an electric two-wheeler manufacturer. The acquisition is for cash consideration; no specific amount was disclosed.
Kalpataru Acquisition Worth ₹52.55 Cr
Kalpataru's subsidiary KPL approved acquiring 16.67% of step-down subsidiaries AREPL and AREDPL for ₹52.55 Crore. This makes them wholly owned, giving Kalpataru 100% of Kalpataru Parkcity project cash flows at Thane.
- Value
- ₹52.55 Cr
- Execution
- 60 days, subject to receipt of requisite approvals
Zydus Lifesciences Acquisition Worth ₹84 Cr
Zydus Lifesciences acquired Sterling Biotech's API business for Rs. 84 Crore via slump sale. The deal covers fermentation-based API products and is completed.
- Value
- ₹84.00 Cr
Zydus Lifesciences Acquisition Worth ₹167 Cr
Zydus Lifesciences completed acquisition of Sterling Biotech's API business for Rs. 167 Crore. The slump sale of fermentation-based API products strengthens its manufacturing portfolio.
- Value
- ₹167.0 Cr
Zydus Lifesciences Acquisition
Zydus Lifesciences completed its acquisition of Sterling Biotech's API business under a September 2024 Business Transfer Agreement. No transaction value was disclosed in this filing.
Arvaya Healthcare Acquisition
Arvaya Healthcare completed the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited on 1 November 2026. The target is now a wholly-owned subsidiary, with no consideration amount disclosed.